Pharmaceutical

Camena bags $10m in funding from Mercia

The bioscience company has received $10m Series A financing from asset manager Mercia.

Jul 3, 2023 - 20:00
Camena bags $10m in funding from Mercia
The bioscience company has received $10m Series A financing from asset manager Mercia.
Read the original article

Tags:

Previous Article

The VPAS fallout continues – Celltrion pulls high-profile biosimilar from UK market

Next Article

Baudax Bio acquires biotechnology firm TeraImmune

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Lykos cuts team by 75%, vows to keep MDMA program despite FDA veto

Lykos cuts team by 75%, vows to keep MDMA program despi...

Aug 17, 2024

AMA asks doctors to de-emphasize use of BMI in gauging health and obesity

AMA asks doctors to de-emphasize use of BMI in gauging ...

Jun 14, 2023

Experts talk detecting disease from voice biomarkers with AI, privacy concerns

Experts talk detecting disease from voice biomarkers wi...

Nov 7, 2023